Seventy-nine patients with panic disorder were randomized to an 8-week double-blind
treatment with alprazolam, imipramine, or placebo. Patients kept daily records of panic …

The antipanic effect and tolerability of alprazolam and imipramine were compared during 9
weeks in 55 inpatients with panic disorder with or without agoraphobia. Both drugs …

This paper reports the results of a double-blind comparison of fixed daily doses of 6 mg of
alprazolam, 2 mg of alprazolam, 225 mg of imipramine, and placebo for 8 weeks in 81 …

Date from a panic disorder treatment study with 506 patients, comparing alprazolam and
placebo in a double-blind manner for 8 weeks, were analyzed to identify demographic and …

As part of the cross‐national collaborative panic study, a double‐blind comparison of
alprazolam, imipramine and placebo was performed in Scandinavian outpatients with panic …

Fifty-five patients completed a 5-week double-blind study comparing alprazolam,
propranolol, and placebo in the treatment of panic disorder and agoraphobia with panic …

A recently reported multinational, 8-week double-blind, placebo-controlled study assessing
the efficacy of alprazolam versus placebo in the treatment of panic disorder indicated …

Forty-eight patients currently experiencing panic attacks were randomly assigned to double-
blind treatment with alprazolam, diazepam, or placebo. Efficacy was assessed using the …

Fifty-five patients with moderate to severe panic disorder were treated for 9 weeks with
alprazolam or imipramine and were then, except for one patient who had committed suicide …

The efficacy of tricyclics and benzodiazepines in the short term (approximately 2–4 months)
treatment of panic disorder is well demonstrated, but efficacy over the longer term is not …